Print   

Tuesday 28 April, 2009

Zone-IP Limited

Final Results


                                                                 28 April 2009

                                 ZONE-IP LTD.

                                  (LSE: ZIP)

                         ("ZONE-IP" OR THE COMPANY")

              FINAL results for the year ENDED 31 December 2008

Chairman's Statement

In the year ended 31 December 2008 the Company incurred a loss on continuing 
operations of $3.9 million (2007: $2.75 million) on turnover of $4.8 million 
(2007: $8.26 million).  As at 31 December 2008, the Company had a cash portfolio 
of $2.9 million (2007: $5.2 million).

During 2008, the Company continued to invest further efforts in the
development of its products. The Company has dramatically improved
videoconferencing experience of its products by launching the HD7000Pro, the
high definition room videoconferencing system. The Company has also released
the VCBPro7, an all-in-one, high definition Multipoint Control Unit
(MCU),which the Board believes is the first MCU on the market to deliver
integrated session-recording and streaming capabilities. The VCBPro7 includes
an embedded MXM, Emblaze-VCON's award-winning, full-feature management tool
for video network management and total gateway functionality for legacy and
advanced technologies. The Company has also begun work on a low-bandwidth
videoconferencing technology targeted at the satellite-based IP communications
market to allow video communications in remote regions of the world where
there is a lack of IP infrastructure.

On the operational side, ZONE-IP's subsidiary, Emblaze-VCON, has implemented
significant cost reductions in order to adjust to the general economic
climate.

Future Prospects

The Board expects that demand for video communication via desktop computers
will increase, specifically in light of the obvious need of organizations to
reduce costs of sales and traveling expenses. The convergence from legacy
analog systems into more advanced IP based products is taking place, however,
at a slower pace than we anticipated. Management will continue to work hard to
strengthen the Company's position. The board continues to seek ways to further
save costs and to operate in the most cost efficient way.

Dr Hans Wagner

Chairman

Enquiries:

Zone-IP Ltd.
Hagit Gal                     +972 9 7699339
 
John East & Partners Limited
David Worlidge                + 44 20 7628 2200
 


CONSOLIDATED BALANCE SHEETS

                                                        31 December

                                         Note       2008          2007

                                                   $'000         $'000
ASSETS
 
CURRENT ASSETS:
Cash and cash equivalents                          2,316         1,968
Restricted cash                                       51         1,257
Short-term available-for-sale marketable  2
securities                                           526           150
Trade receivables                         3        1,322         2,383
Other accounts receivable and prepaid
expenses                                             252           529
Inventories                                        2,547         2,730
 
Total current assets                               7,014         9,017
 
NON-CURRENT ASSETS:
Long-term available-for-sale marketable   2
securities                                             -         1,869
Property and equipment                               349           397
Intangible assets                         4          400           650
 
Total non-current assets                             749         2,916
 
Total assets                                       7,763        11,933


CONSOLIDATED BALANCE SHEETS

                                                      31 December

                                        Note        2008          2007

                                                   $'000         $'000
LIABILITIES AND EQUITY
 
CURRENT LIABILITIES:
Short-term bank credit                             2,282         2,330
Trade payables                                       882         3,042
Employees and payroll accruals                       680           515
Related party                            6            15            53
Government grants                                    804           767
Deferred revenues                                     92           203
Accrued expenses and other liabilities               642           429
 
Total current liabilities                          5,397         7,339
 
NON-CURRENT LIABILITIES:
Government grants                                    480           593
Employees benefits liability                         356           232
Loan from related party                  6d        1,032             -
 
Total non-current liabilities                      1,868           825
 
Liabilities attributed to discontinued
operations                                           111           111
 
Total liabilities                                  7,376         8,275
 
EQUITY:
Ordinary shares                                      109           109
Share premium                                     13,407        13,203
Net unrealized losses reserve                          -         (139)
Capital reserve from transaction with    6d
controlling shareholder                              250             -
Foreign currency translation reserve                  17             4
Accumulated deficit                             (13,396)       (9,519)
 
Total equity                                         387         3,658
 
Total liabilities and equity                       7,763        11,933



CONSOLIDATED STATEMENTS OF OPERATIONS

                                                    For the year ended
                                                        31 December

                                                    2008          2007

                                                   $'000         $'000
Continuing Operations:
 
Revenues                                           4,803         8,265
Cost of revenues                                 (1,961)       (3,294)
 
Gross profit                                       2,842         4,971
 
Operating expenses:
Research and development                           3,052         3,019
Selling and marketing                              2,044         2,682
General and administrative                         2,418         1,840
 
Total operating expenses                           7,514         7,541
 
Operating loss                                   (4,672)       (2,570)
Finance income                                       371           594
Finance costs                                    (1,192)         (832)
Other income (Note 4)                              1,616             -
 
Loss for the period from continuing operations   (3,877)       (2,808)
 
Discontinued Operation:
 
Income for the period from a discontinued operation    -            85
 
Net loss for the year                            (3,877)       (2,723)
 
Loss per share:
 
Basic and diluted loss per share from 
continuing operations                            $(0.08)       $(0.05)
Basic and diluted loss per share from a 
discontinued operation                           $(0.00)       $(0.00)
 
Basic and diluted loss per share                 $(0.08)       $(0.05)
 
Weighted average number of shares used in
computing basic and diluted loss per share    51,120,253    51,120,253



CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

                                          Capital
                                          reserve
                                             from                Foreign
                                      transaction        Net    currency
                                             with unrealized translation
                                      controlling       loss
                       Share    Share                        adjustments Accumulated     Total
                     capital  premium shareholder    reserve     reserve     deficit    equity

                       $'000    $'000       $'000      $'000       $'000       $'000     $'000
 
Balance as of 1                                 -
January 2007             109   12,989                   (10)         (2)     (6,796)     6,290
 
Foreign currency
translation                -        -                      -           6           -         6
Net loss on
available-
for-sale financial
assets                     -        -                  (129)           -           -     (129)
Share-based payment        -      214                      -           -           -       214
Net loss                   -        -           -          -           -     (2,723)   (2,723)
 
Balance as of 31                                -
December 2007            109   13,203                  (139)           4     (9,519)     3,658
 
Foreign currency                                -
translation                -        -                      -          13           -        13
Capital reserve
from
controlling                                   250
shareholder's
loan                       -        -                      -           -           -       250
Net gain on
available-
for-sale financial
assets                     -        -           -        139           -           -       139
Share-based payment        -      204           -          -           -           -       204
Net loss                   -        -           -          -           -     (3,877)   (3,877)
 
Balance as of 31                              250
December 2008            109   13,407                      -          17    (13,396)       387



CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                            Year ended
                                                            31 December

                                                         2008         2007

                                                        $'000        $'000
Cash flows from operating activities:
Net loss                                              (3,877)      (2,723)
Adjustments to reconcile the net loss to net cash
used in operating activities:
 
Income from discontinued operations                         -         (85)
Depreciation and amortization                             462          522
Capital gain from sale of intangible assets           (1,616)            -
Share-based payment                                       204          214
Increase in employee benefits liability                   124           83
Impairment of marketable securities                       228            -
Amortization of premium and discount of
marketable securities                                      62           41
Increase in short and long-term Government
grants payables                                          (76)         (64)
 
Working capital adjustments:
Decrease /(increase) in trade receivables               1,061        (722)
Decrease /(increase) in other accounts receivable
and prepaid expenses                                      277        (141)
Decrease /(increase) in inventories                       115      (1,437)
Increase /(decrease) in trade payables                (2,160)        1,459
(Decrease) /increase in employees and payroll
accruals                                                  165        (112)
Decrease in deferred revenues                           (111)        (268)
Increase in accrued expenses and other liabilities        213           41
 
Net cash flows used in continuing operating
activities                                            (4,929)      (3,192)
Net cash flows used in discontinued operating
activities                                                  -         (54)
 
Net cash used in operating activities                 (4,929)      (3,246)
 
Cash flows from investing activities:
Purchase of property and equipment                      (102)         (26)
Proceeds from sale of intangible assets, net            1,622            -
Restricted cash                                         1,206      (1,020)
Investment in marketable securities                     (250)      (2,680)
Proceeds from sale of marketable securities             1,592        5,970
 
Net cash provided by investing activities               4,068        2,244
 
Cash flows from financing activities:
(Decrease) /increase in short-term bank credit           (48)        1,815
Loan from related party                                 1,282            -
Decrease in related party                                (38)        (460)
 
Net cash provided by financing activities               1,196        1,355
 
Increase in cash and cash equivalents                     335          353
Net foreign exchange difference                            13            2
Cash and cash equivalents at beginning of year          1,968        1,613
 
Cash and cash equivalents at end of period              2,316        1,968



CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                            Year ended
                                                            31 December

                                                         2008         2007

                                                        $'000        $'000
(1) Supplemental disclosure of cash flow activities:
 
    Interest received                                     320          302
 
    Interest paid                                         119           72
 
    Tax paid                                               15           15
 
(2) Non-cash activities:
 
    Transfer from inventories to property and
    equipment                                              68          114
 
    Property acquired through suppliers' credit             -           34
 
    Capital reserve from loan with controlling
    shareholder                                           250            -
 
(3) Net cash flows used in discontinued operating
    activities:
 
    Profit from a discontinued operation                    -           85
    Less: decrease in accrued expenses associated
    with the discontinued operation                         -        (139)
 
                                                            -         (54)

NOTES TO THE FINANCIAL STATEMENTS

All references to $ are to US Dollars in thousands

NOTE 1:-. The financial information for the year ended 31 December 2007 is
extracted from the Group's financial statements to that date which received an
unqualified auditor's report. The financial information for the year ended 31
December 2008 is extracted from the Group's unaudited financial statements to
that date.

NOTE 2:- Available-for-sale marketable securities

Short-term available-for-sale marketable securities as of 31
December 2007 (none in 2008) were all with contractual maturities of less than
1 year as follows:

                                                       31
                                                    December
                                                      2007
                              Effective
                               interest  Amortized  Unrealized  Market
                                   rate       cost      losses   value

                                             $'000       $'000   $'000
                               3.88 per
Corporate debentures              cent.        150           -     150

Long-Term Available-for-Sale Marketable securities as of 31
December, 2008 and 2007 were all with contractual maturities of more than 1
year as follows:

                                                       31
                                                    December
                                                      2008
                              Effective
                               interest  Amortized    Realized  Market
                                   rate       cost      losses   value
Mature after one year and
less than five years:                        $'000       $'000   $'000
 
                               2.28 per
Corporate debentures              cent.        754       (228)     526


                                                        31
                                                     December
                                                       2007
                              Effective
                               interest  Amortized  Unrealized  Market
                                   rate       cost      losses   value
Mature after one year and
less
than five years:                             $'000       $'000   $'000
 
                               5.54 per
Corporate debentures              cent.      1,407       (144)   1,263
Foreign bonds denominated in   5.45 per
U.S. dollar                       cent.        601           5     606
 
                                             2,008       (139)   1,869


During 2008, the Company recorded impairment losses of $ 228,000
due to the recent credit crisis which impacted the fair value of the Company's
investments in its available-for-sale marketable securities and caused a
severe decline in the fair value of its investments.

NOTE 3- Trade Receivables

Trade receivables are non-interest bearing. They are generally on 60-90 credit
day terms.

                                               31 December

                                           2008          2007

                                          $'000         $'000
Trade receivables                         1,784         2,514
Less - allowance for doubtful
accounts                                  (462)         (131)
 
Trade receivables, net                    1,322         2,383


The movement in the allowance for doubtful accounts is as follows:

                                                Allowance for
                                                     doubtful
 
                                                     accounts
                                                        $'000
 
Balance as of 1 January, 2007                             179
Provision, net of recoveries                               64
Write-off                                               (112)
 
Balance as of 31 December, 2007                           131
Provision, net of recoveries                              331
Write-off                                                   -
 
Balance as of 31 December, 2008                           462


Impaired debts are accounted for through recording an allowance for doubtful
accounts.

NOTE 4:- Intangible Assets

                                       Core   Developed
                                 technology  technology   Total

                                      $'000       $'000   $'000
Cost:
 
At 1 January 2007                       577         648   1,225
 
At 31 December 2007                     577         648   1,225
Disposals                                 -        (21)    (21)
 
At 31 December 2008                     577         627   1,204
 
Amortization and impairment:
 
At 1 January 2007                       125         206     331
Amortization                             82         162     244
 
Balance at 31 December 2007             207         368     575
Disposals                                 -        (15)    (15)
Amortization                             82         162     244
 
At 31 December 2008                     289         515     804
 
Net book value:
At 31 December 2008                     288         112     400
 
At 31 December 2007                     370         280     650
 
At 1 January 2007                       452         442     894


Amortization expense is recorded in cost of sales.

During 2008, EVC has entered into an agreement to sell certain of
its patents to Handheld Devices in consideration of $ 3,200 in cash. EVC
received out of the consideration $ 1,622, net of payments to the Office of
the Chief Scientist of the Ministry of Industry and net of commissions payable
to a firm of patent attorneys, which introduced the buyer to EVC, and
associated legal fees.

NOTE 5: - Income Taxes

a. Israeli taxation:

1. Corporate tax rate:

On 25 July 2005, the Israeli Parliament approved an amendment to
the Income Tax Ordinance (No. 147) 2005, which prescribes, among others, a
gradual decrease in the corporate tax rate in Israel to the following tax
rates: in 2008 - 27 per cent., in 2009 - 26 per cent., 2010 and thereafter -
25 per cent.

2. EVC submitted an application to assign the programs of VCON
under the Law for the Encouragement of Capital Investments, 1959 ("the Law")
to EVC and thus enjoy the tax benefits (primarily reduced tax rates) of an
"Approved Enterprise" as defined by the Law. The application was approved by
the Israel Investment Center (a department of the Ministry of Industry, Trade
and Labor).

The Company's production facilities in Israel have been granted
"Approved Enterprise" status, for 6 investment programs approved under the
Law. According to the provisions of the Law, the Company has elected the
"alternative benefits" track, the waiver of grants in return for a tax
exemption and, accordingly, the Company's income from the "Approved
Enterprise" is tax exempt for a period of two years commencing with the year
it first earns taxable income and afterwards is entitled to a reduced tax rate
of 10 per cent to 25 per cent for an additional period of five to eight years
(depending on the level of foreign investment in the Company).

The entitlement to the above benefits is conditional upon the
fulfillment of the conditions stipulated by the above Law, regulations
published there under and the letters of approval for the specific investments
in "Approved Enterprises". In the event of failure to comply with these
conditions, the benefits may be cancelled and the Company may be required to
refund the amount of the benefits, in whole or in part, including interest.

The period of tax benefits, detailed above, is subject to limits of
the earlier of 12 years from the commencement of production, or 14 years from
the approval date. These limitation do not apply to the tax exempt period of
the first two years.

Income from sources other than the "Approved Enterprise" during the
benefit period will be subject to tax at the regular corporate tax rate.

3. On 1 April 2005, an amendment to the Investment Law came into
effect ("the Amendment") and has significantly changed the provisions of the
Investment Law. The Amendment limits the scope of enterprises which may be
approved by the Investment Center by setting criteria for the approval of a
facility as an Approved Enterprise, such as provisions generally requiring
that at least 25 per cent. of the Approved Enterprise's income will be derived
from export. Additionally, the Amendment enacted major changes in the manner
in which tax benefits are awarded under the Investment Law so that companies
no longer require Investment Center approval in order to qualify for tax
benefits.

4. However, the Investment Law provides that terms and benefits
included in any letter of approval already granted will remain subject to the
provisions of the law as they were on the date of such approval. Therefore the
Israeli subsidiary's existing Approved Enterprise will generally not be
subject to the provisions of the Amendment.

EVC is an "industrial company" under the Law for the Encouragement
of Industry (Taxation), 1969 and as such is entitled to certain tax benefits,
including a reduction in the purchase price for patents or certain other
intangible property rights at the rate of 12.5 per cent. per year beginning
with the first year the Company used such intangible property rights and the
deduction of public offering expenses over three years.

b. Carry forward tax losses:

As of 31 December 2008, the Company has carry forward tax losses of
approximately $ 11,000 (2007: approximately $ 11,000) that can be carried
forward indefinitely.

As of 31 December 2008, EVC has carry forward tax losses of
approximately $ 7,800 (2007: approximately $ 5,000) that can be carried
forward indefinitely.

As of 31 December 2008, the U.S. subsidiary had U.S. federal carry
forward tax losses of approximately $ 4,700 (2007: $ 4,900) that can be
carried forward and offset against taxable income for 15-20 years and expire
between 2020 and 2025.

Management currently believes that since the Company and its
subsidiaries have no history of ongoing profits it is not probable that the
deferred tax asset in respect of the loss carry forwards and other temporary
differences, in the amount of $ 2,034 (2007 - $ 2,013), mainly due to research
and development differences, will be realized.

c. Tax assessments:

The Company received final tax assessments through 2004.

NOTE 6: - Related Party Disclosure

a. Compensation of key management personnel of the Group:

                                               31 December,
                                             2008        2007

                                            $'000       $'000

Short-term employee benefits                  158         308
Severance pay                                   -          18
Share-based payments                            -          61
 
Total compensation paid to key
management personnel                          158         387


Directors' interests in an employee stock option plan:

Share options held by executive members of the Board of Directors
to purchase ordinary shares have the following expiry dates and exercise
prices:

                                 Exercise
Issue date     Expiry date          price         2008         2007
                                                Number       Number
                                           outstanding  outstanding
 
2006                  2016          $0.44      250,000      250,000
2007                  2017          $0.49    1,278,006    1,278,006


No share or options have been granted to the non-executive members
of the Board of Directors under this scheme.

b. Entities with significant influence over the Group:

Emblaze Ltd. owns 64.88 per cent. of the ordinary shares in Zone IP
Ltd.

Transactions

                                          Year ended
                                          31 December,

                                       2008         2007

                                      $'000        $'000
 
Rent and utilities expenses             146           80
c. Balances

Amount owed to Emblaze at 31 December 2008 and 2007 was $ nil and
$53, respectively.

d. During December 2008, the Company received a loan in the amount
of $ 1,282 from certain of the Company's controlling shareholders ("lenders").
The loan does not bear any interest and will be repaid to the lenders five
years following the effective date. The Company recorded a capital reserve in
the amount of $ 250 in respect with the loan received from the lenders.

NOTE 7:- Dividends

No dividends have been declared for the year ended 31 December 2008.

NOTE 8:- Copies of the Report and Accounts will be sent to shareholders in due
course and will be available from the Company's website at www.zone-ip.com.


Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.